These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 985538)

  • 81. [Comparative activity of some biguanides, sulfonylureas and their combinations on blood sugar and lactic acid in the guinea pig. II].
    Bramanti G; Bianchini P; De Fina V; Dell'Omodarme G
    Boll Chim Farm; 1971 Apr; 110(4):226-36. PubMed ID: 5111348
    [No Abstract]   [Full Text] [Related]  

  • 82. Hepatic effects of oral hypoglycemic drugs.
    Davidoff F
    Fed Proc; 1977 Dec; 36(13):2724-7. PubMed ID: 336410
    [No Abstract]   [Full Text] [Related]  

  • 83. [Effects of biguanides on peripheral tissues].
    Butterfield WJ
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():644-55. PubMed ID: 5371310
    [No Abstract]   [Full Text] [Related]  

  • 84. Phosphinylguanidines. Phosphorus analogs of biguanides.
    Fanshawe WJ; Bauer VJ
    J Med Chem; 1967 Mar; 10(2):273. PubMed ID: 6034079
    [No Abstract]   [Full Text] [Related]  

  • 85. Structural basis of mammalian respiratory complex I inhibition by medicinal biguanides.
    Bridges HR; Blaza JN; Yin Z; Chung I; Pollak MN; Hirst J
    Science; 2023 Jan; 379(6630):351-357. PubMed ID: 36701435
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Metformin selectively targets redox control of complex I energy transduction.
    Cameron AR; Logie L; Patel K; Erhardt S; Bacon S; Middleton P; Harthill J; Forteath C; Coats JT; Kerr C; Curry H; Stewart D; Sakamoto K; Repiščák P; Paterson MJ; Hassinen I; McDougall G; Rena G
    Redox Biol; 2018 Apr; 14():187-197. PubMed ID: 28942196
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The mechanisms of action of metformin.
    Rena G; Hardie DG; Pearson ER
    Diabetologia; 2017 Sep; 60(9):1577-1585. PubMed ID: 28776086
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Metformin as a cellular protector; a synoptic view of modern evidences.
    Wiernsperger N
    J Nephropharmacol; 2015; 4(1):31-36. PubMed ID: 28197472
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Changes in [18F]Fluoro-2-deoxy-D-glucose incorporation induced by doxorubicin and anti-HER antibodies by breast cancer cells modulated by co-treatment with metformin and its effects on intracellular signalling.
    Cooper AC; Fleming IN; Phyu SM; Smith TA
    J Cancer Res Clin Oncol; 2015 Sep; 141(9):1523-32. PubMed ID: 25579456
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Molecular mechanism of action of metformin: old or new insights?
    Rena G; Pearson ER; Sakamoto K
    Diabetologia; 2013 Sep; 56(9):1898-906. PubMed ID: 23835523
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Phenformin and 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) activation of AMP-activated protein kinase inhibits transepithelial Na+ transport across H441 lung cells.
    Woollhead AM; Scott JW; Hardie DG; Baines DL
    J Physiol; 2005 Aug; 566(Pt 3):781-92. PubMed ID: 15919715
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Relationship between hypoglycaemic response and plasma concentrations of BTS 67 582 in healthy volunteers.
    Byrom WD; Rotherham NE; Bratty JR
    Br J Clin Pharmacol; 1994 Nov; 38(5):433-9. PubMed ID: 7893585
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Phenylalkyloxirane carboxylic acids, a new class of hypoglycaemic substances: hypoglycaemic and hypoketonaemic effects of sodium 2-[5-(4-chlorophenyl)-pentyl]-oxirane-2-carboxylate (B 807-27) in fasted animals.
    Wolf HP; Eistetter K; Ludwig G
    Diabetologia; 1982 Jun; 22(6):456-63. PubMed ID: 6213437
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Influence of phenformin and metformin on exercise induced lactataemia in patients with diabetes mellitus.
    Björntorp P; Carlström S; Fagerberg SE; Hermann LS; Holm AG; Scherstén B; Ostman J
    Diabetologia; 1978 Aug; 15(2):95-8. PubMed ID: 700278
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Metformin-induced lactic acidosis in the presence of acute renal failure.
    Assan R; Heuclin C; Ganeval D; Bismuth C; George J; Girard JR
    Diabetologia; 1977 May; 13(3):211-7. PubMed ID: 406158
    [No Abstract]   [Full Text] [Related]  

  • 96. On the mechanism of action of hypoglycemia-producing biguanides. A reevaluation and a molecular theory.
    Schäfer G
    Biochem Pharmacol; 1976 Sep; 25(18):2005-14. PubMed ID: 985538
    [No Abstract]   [Full Text] [Related]  

  • 97. Some new aspects on the interaction of hypoglycemia-producing biguanides with biological membranes.
    Schäfer G
    Biochem Pharmacol; 1976 Sep; 25(18):2015-24. PubMed ID: 985539
    [No Abstract]   [Full Text] [Related]  

  • 98. [Glucose-lactic acid metabolism during clinical use of biguanides].
    Pedersen J
    Ugeskr Laeger; 1973 Jul; 135(31):1632-5. PubMed ID: 4585752
    [No Abstract]   [Full Text] [Related]  

  • 99. [Causes of the blood sugar decreasing effect of biguanides].
    Berger W
    Schweiz Rundsch Med Prax; 1970 Aug; 59(34):1203-6. PubMed ID: 5513428
    [No Abstract]   [Full Text] [Related]  

  • 100. Biguanides and lactate metabolism: a review.
    Hermann LS
    Dan Med Bull; 1973 Jun; 20(3):65-79. PubMed ID: 4594325
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.